Matthew F. Omojola
Matthew F. Omojola publishes mostly in Neurology, Surgery and Pulmonary and Respiratory Medicine, on topics such as Intracranial Aneurysms: Treatment and Complications, Vascular Malformations Diagnosis and Treatment and Intracerebral and Subarachnoid Hemorrhage Research.
- World rank
- #4,528,208 of 7,710,434 ranked researchers
- Rank in United States
- #1,203,184 of 1,627,098
- Works
- 48
- Citations
- 699
- Citations per work
- 14.6
What does Matthew F. Omojola research?
Matthew F. Omojola's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2653.2%
- Medicine2653.2%
- Everything else2042.4%
- Life Sciences24.4%
- 1Neurology21% of their works
- 2Surgery15% of their works
- 3Pulmonary and Respiratory Medicine8% of their works
- 4Rheumatology6% of their works
- 5Molecular Biology4% of their works
- 6Endocrinology, Diabetes and Metabolism4% of their works
Research topics
- Intracranial Aneurysms: Treatment and Complications
- Vascular Malformations Diagnosis and Treatment
- Intracerebral and Subarachnoid Hemorrhage Research
- Cerebral Venous Sinus Thrombosis
- Neurosurgical Procedures and Complications
- Parasitic infections in humans and animals
- Bone Tumor Diagnosis and Treatments
- Moyamoya disease diagnosis and treatment
Which keywords describe Matthew F. Omojola's research?
The keywords of their largest research topics: Endovascular Treatment, Anticoagulant Therapy, Aneurysmal Subarachnoid Hemorrhage, Arteriovenous Malformations, Cerebral Cavernous Malformations, Intracranial Aneurysms, Cerebral Amyloid Angiopathy and Intracerebral Hemorrhage.
- RNF213 Gene
- Moyamoya Disease
- Idiopathic Intracranial Hypertension
- Chordoma
- Cerebrospinal Fluid Leaks
- Intracerebral Hemorrhage
- Intracranial Aneurysms
- Arteriovenous Malformations
- Anticoagulant Therapy
- Endovascular Treatment
- Aneurysmal Subarachnoid Hemorrhage
- Cerebral Cavernous Malformations
- Cerebral Amyloid Angiopathy
- Cerebral Venous Thrombosis
- Chondrosarcoma
- Echinococcosis
- Intracranial Hypotension
- Neurocysticercosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Endovascular Treatment122 topics
- Anticoagulant Therapy82 topics
- Aneurysmal Subarachnoid Hemorrhage61 topic
- Arteriovenous Malformations61 topic
- Cerebral Cavernous Malformations61 topic
- Intracranial Aneurysms61 topic
- Cerebral Amyloid Angiopathy51 topic
- Intracerebral Hemorrhage51 topic
- Cerebral Venous Thrombosis31 topic
- Cerebrospinal Fluid Leaks31 topic
- Chondrosarcoma31 topic
- Chordoma31 topic
- Echinococcosis31 topic
- Idiopathic Intracranial Hypertension31 topic
- Intracranial Hypotension31 topic
- Moyamoya Disease31 topic
- Neurocysticercosis31 topic
- RNF213 Gene31 topic
Where does Matthew F. Omojola work?
Matthew F. Omojola's main affiliation in the publication record is University of Nebraska Medical Center, United States.
How many publications and citations does Matthew F. Omojola have?
OpenAlex counts 48 works and 699 citations for Matthew F. Omojola, an h-index of 16, ranking #4,528,208 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Matthew F. Omojola. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.